(Q44394263)

2 December 2017

title

Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection (English)

1 reference

2 December 2017

Yönem A

1

1 reference

2 December 2017

Cakir B

2

1 reference

2 December 2017

Güler S

3

1 reference

2 December 2017

Azal O O

4

1 reference

2 December 2017

Corakçi A

5

1 reference

2 December 2017

publication date

1 October 2001

1 reference

Diabetes, Obesity and Metabolism

2 December 2017

published in

1 reference

2 December 2017

volume

3

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

332-337

1 reference

Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Oxygen Metabolism and the Toxic Properties of Phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Endogenous haemopoietic growth factors in neutropenia and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Leukocytes and the risk of ischemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00142.X

10.1046/J.1463-1326.2001.00142.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference